Introduction. Hypotonic fluids have been associated with the development of iatrogenic hyponatremia. Objectives. To assess variations in serum sodium (sNa) following the intravenous administration of isotonic maintenance fluids (0.9% NaCl/5% dextrose) compared to hypotonic maintenance fluids (0.45% NaCl/5% dextrose). Material and Methods. Randomized, controlled, double-blind clinical trial. Pediatric patients with an expected length of stay in the intensive care unit of more than 24 hours were enrolled, with normal serum Na, and IV fluids >80% of total maintenance fluids. Serum Na level was measured before administering maintenance fluids and when reducing the administration to <80% of total fluids. Results. The study included 63 patients who were randomly assigned to receive hypotonic (n= 32) or isotonic (n= 31) maintenance fluids. Baseline characteristics were similar in both groups. There were no differences in terms of volume of fluid administered (hypotonic group: 865 ± 853 mL; isotonic group: 778 ± 649 mL; p= 0.654) or infusion duration (hypotonic group: 24 ± 10.8 hours; isotonic group: 27.6 ± 12.8 hours; p= 0.231). A difference was found in the serum Na following the administration of maintenance fluids (hypotonic group: 137.8 ± 4.3 mmol/L; isotonic group: 140.0 ± 4.1 mmol/L, p= 0.04). None of these two maintenance fluids increased the risk of hyponatremia (Na <135 mmol/L) or hypernatremia (Na >145 mmol/L). Conclusions. Neither hypotonic nor isotonic maintenance fluids increased the risk of developing iatrogenic hyponatremia with the 24 hour infusion.
INTRODUCTION
Maintenance fluids (MF) are necessary to warrant water and electrolyte supply in patients who are unable to have oral fluids. The optimal composition of these fluids for pediatric patients is still unknown.
In 1956, Holliday and Segar 1 suggested that IV electrolytes used in maintenance fluids could be similar to those of breast milk (NaCl 10-30 mmol/L). Hypotonic maintenance fluids in healthy children should not be associated with any risk, but they could have harmful consequences in ill children with impaired free water excretion.
Since the 1980s, numerous publications have described the development of severe neurological morbidity and death secondary to iatrogenic hyponatremia. [2] [3] [4] In spite of the quality and volume of infusions administered, serum sodium concentration is usually within normal limits (135-145 mmol/L).
Water and sodium homeostasis is one of the major functions of the kidneys through free water excretion. Several stimuli have been described for antidiuretic hormone secretion; many of them are common in critically ill patients, such as respiratory and digestive tract infections, pain, nausea, opioid use, and the post-surgical period. [5] [6] [7] Therefore, maintenance fluids containing large quantities of free water could induce iatrogenic hyponatremia in these patients. Due to an increased number of reports of iatrogenic hyponatremia cases related to permanent brain injury and brain death, several authors currently recommend the use of isotonic fluids as maintenance therapy for pediatric patients. [8] [9] [10] [11] In spite of the growing evidence that indicates that hypotonic fluids increase the risk of hyponatremia, there are few prospective clinical trials confirming such risk in pediatric patients. 8 In Argentina, some facilities still use maintenance fluids containing 0.18-0.3% NaCl (30-45 mmol/L) in 5% dextrose with no control of serum Na at the beginning of or during the infusion. 12 The main objective of this clinical trial was to assess the difference in serum Na using two maintenance fluids of different tonicity, isotonic maintenance fluid (IMF) (0.9% NaCl/5% dextrose) and hypotonic maintenance fluid (HMF) (0.45% NaCl/5% dextrose) for less than 48 hours following admission to a Pediatric Intensive Care Unit (PICU).
MATERIAL AND METHODS Protocol
A prospective, controlled, double-blind, randomized clinical trial was conducted at the PICU of the Hospital General de Niños "Pedro de Elizalde" (HGNPE) between February 1 and October 31, 2011. Eligibility criteria included children from 1 month to 18 years old with an expected length of stay at the PICU of more than 24 hours, with normal serum Na (135-145 mmol/L) measured at the time of admission to the PICU or after IV fluid resuscitation, and requiring >80% of IV fluids out of the total maintenance fluid administration. Patients were excluded if they had previous kidney failure (serum creatinine >1 mg/dL in children ≤3 years old, and serum creatinine >1.5 mg/dL in children >3 years old), liver failure with ascites and portal hypertension, adrenal insufficiency, nephrotic or nephritic syndrome, Kawasaki disease, sickle cell disease, diabetes insipidus, congenital metabolic disease, plasma glucose >200 mg/dL, required total parenteral nutrition or hyperhydration (patients receiving cancer treatment or with risk of tumor lysis syndrome), and those re-admitted to the PICU. Patients in whom a second sample of serum Na was not obtained were excluded from the study.
Once parents provided their informed consent, children were randomly assigned to two groups: the hypotonic group (HMF), who received maintenance fluids with a Na concentration of 77 mmol/L, and the isotonic group (IMF), who received maintenance fluids with a Na concentration of 154 mmol/L. The addition of up to 20 mmol/L of potassium to maintenance fluids of both groups was the treating physician's decision. Glucose concentrations were the same in both groups (5% dextrose). Maintenance fluids were prepared and masked by research pharmacists. Maintenance fluids were prepared under a class 2X biosafety laminar vertical flow and stored in tight individual bags at a temperature of 2-8°C until they were dispensed with the corresponding randomization code. Fluid volume was estimated using the HGNPE's standards: 1500 mL/m 2 if the patient's weight was >10 kg, and 80 mL/kg of the patient's weight was ≤10 kg, every 24 hours.
The treating physician could discontinue treatment with maintenance fluids and withdraw the patient from the protocol at any time if he/she considered that it was necessary to change the Na infusion concentration. Treating physicians were aware of sodium concentration results of patients enrolled in the study in order to manage adverse events related to serum Na alterations.
The primary outcome measure was the change in serum Na (mmol/L) between the baseline and the final value produced by the maintenance fluid infusion. Serum Na was measured before randomization and when patients reached >20% of the total oral fluid intake or after 48 hours of starting the maintenance fluid infusion, because most PICU patients usually achieve a complete enteral nutrition in the first 48 hours of hospitalization or when parenteral nutrition is prescribed. Serum Na and glucose levels were determined using a blood gas and electrolyte analyzer (Gem Premier 3000, Instrumentation Laboratory, Lexington, MA, USA). Values were considered as follows: normal serum Na level: 135-145 mmol/L, hyponatremia: <135 mmol/L, severe hyponatremia: <130 mmol/L; and hypernatremia >145 mmol/L. Secondary outcome measures included 28 day mortality after randomization, number of days without mechanical ventilation at 28 days since the admission to the PICU, length of stay in the PICU (days), presence of hyponatremia and hypernatremia, and number of patients with severe hyponatremia.
Two external observers reviewed the results once half of the population had been recruited; no risks were found that would prevent the study completion.
This study was approved by the Institutional Review Board of the Teaching and Research Department and the Bioethics Committee (NCT01301274).
Sample size calculation
The sample size was calculated based on the primary outcome of the study. The minimum serum Na reduction was estimated at 2 mmol/L in patients on hypotonic maintenance fluids, with a standard deviation of 2 mmol/L. 12 Considering an alpha error of 0.05 and a 90% power to detect such difference, the sample size was estimated at 30 patients per group plus patients lost to followup.
Randomization
Patients were assigned to HMF or IMF administration according to a computergenerated randomization list (Microsoft Excel 2007) in a four block design. The randomization code was maintained by the research pharmacist and kept blinded to all staff members in charge of indicating and prescribing the maintenance fluids. These were prepared and coded at the pharmacy, and all participants, nurses, medical and research staff members, researchers (except pharmacists) and members of the safety monitoring committee were unaware of sodium concentration in administered fluids.
Statistical analysis
Continuous data were expressed as mean ± standard deviation (SD) or as median and interquartile (IQ) range, and they were compared using the Student's t test or the Mann-Whitney U test (non parametric data). Categorical data were presented as rates and compared using an c 2 test or Fisher's exact test. The significance level during the study was established at <0.05. Results were analyzed using the STATA 9.0 software for Windows (Copyright 1984 (Copyright -2003 Stata Corporation 4905 Lakeway Drive College Station, TX, USA).
RESULTS
Between February 1 and October 31, 2011, 251 patients were admitted to the HGNPE's PICU; 94 patients were eligible for this study; and finally 66 pediatric patients were randomized. It was not possible to obtain a second measurement of serum Na in three patients and they were excluded from the final data analysis. A total of 63 patients were included ( Figure 1 ). Thirty two patients were randomly assigned to hypotonic maintenance fluids, and 31 to isotonic maintenance fluids.
There were no differences between groups in terms of their baseline characteristics: age, gender, weight, Pediatric Index of Mortality 2 (PIM2), condition (clinical or surgical), and serum Na ( Table 1) . There were also no differences between the groups in relation to the volume and duration of the maintenance fluid administration ( Table 2) . Patients received less maintenance fluids than the standard maintenance rate (100 mL/kg/day with a weight of up to 10 kg): 37% less in the HMF group and 23% less in the IMF group. There were no difference between groups in the number of days without mechanical ventilation, length of stay in the PICU, and 28 day mortality. The three patients who died and received hypotonic maintenance fluids maintained a sodium concentration above 130 mmol/L throughout the study, and the cause of death apparently was not related to the maintenance fluid infusion ( Table 3) . Final serum Na (mmol/L) (mean ± SD) 137.8 ± 4.3 140 ± 4.1 0.04
Days without mechanical ventilation (mean ± SD) 19.9 ± 7.9 21,5 ± 6.6 0.40
Length-of-stay in the PICU (days) (mean ± SD) 8.5 ± 5.5 12 ± 11.5 0.13
Patients with hypernatremia (n) (%) 2 (6.7) 1 (3. T h e r e w a s o n l y o n e c a s e o f s e v e r e hyponatremia (serum Na <130 mmol/L) in a patient receiving HMF.
DISCUSSION
The results obtained in this clinical trial showed that hypotonic maintenance fluids caused a higher reduction in serum Na, while isotonic maintenance fluids did not produce any alteration in serum Na of critically ill pediatric patients. These results were similar to those observed in a clinical trial conducted by Álvarez Montañana, et al. 13 and confirmed by a metaanalysis 11 indicating that the administration of a hypotonic maintenance fluid is a significant risk factor for iatrogenic hyponatremia in children.
A recent study demonstrated a reduction of hyponatremia in children after surgery receiving an isotonic maintenance fluid, with no development of iatrogenic hypernatremia. In this study, elevated levels of antidiuretic hormone (ADH) were observed in the first 24 hours following non osmotic stimuli for ADH secretion.
14 Reduction in serum Na could be explained by a sodium deficit or a positive electrolyte-free water (EFW) balance. High ADH levels impact EFW secretion, and several non osmotic stimuli have been shown to increase ADH secretion. 5, 8, 14, 15 Both maintenance fluids administered to the patients in our study contained enough sodium to meet daily demands; 1 for this reason, reduced serum Na could be attributed to the excess EFW intake in hypotonic maintenance fluids. In our study, the absolute value of serum Na reduction was not clinically significant because sodium concentration levels were below 130 mmol/L in just one patient, who had no clinical manifestations.
However, taking into consideration that patients in our study received a lower volume of maintenance fluids than that described by Holliday and Segar in 1959 (37% lower for HMF and 23% lower for IMF), serum Na reduction could have been more relevant if 100% of the volume of maintenance fluids traditionally proposed had been administered. 1 Álvarez Montañana, et al. suggested that the possibility of developing hyponatremia with an hypotonic maintenance fluid infusion is cumulative depending on the infusion duration. 13 Kannan, et al. observed a lower incidence of hyponatremia when patients received 75% of the standard maintenance rates versus standard rates. 16 Hypotonic maintenance fluids at high rates have been associated with morbidity and mortality in pediatric patients due to iatrogenic hyponatremia. 4, [17] [18] [19] [20] Some authors suggest that the use of a lower volume of maintenance fluids would be equal to or even more effective to prevent hospital-acquired hyponatremia than the administration of isotonic maintenance fluids.
12,13, 21 Neville, et al. found that the risk of hyponatremia was reduced with the use of isotonic maintenance fluids, but this did not occur when the volume of administered maintenance fluids was restricted. 22 The present study was not intended to compare variations in serum Na caused by the administration of different volumes of maintenance fluids.
The principal limitation of this study was that ADH levels could not be measured. However, the increase of ADH levels in hospitalized pediatric patients has been described in different studies. 5, 8, 14, 15 In our study, few patients were withdrawn and in all a serum Na measurement was made at baseline. In many of the clinical trials cited here serum Na was not measured before the administration of maintenance fluids, and this could have resulted in an over-estimation
